(Fighting New Coronary Pneumonia) The Canadian government pre-orders two oral anti-coronavirus drugs
China News Service, Toronto, December 4 (Reporter Yu Ruidong) The Canadian government announced on December 3 that it had signed agreements with two pharmaceutical companies, Merck (known as Merck in the United States and Canada) and Pfizer. Pre-order oral anti-coronavirus drugs.
However, Canadian officials have not yet approved any oral anti-coronavirus drugs.
Both Merck and Pfizer have recently submitted their oral drug approval applications to the Canadian Ministry of Health.
The Canadian government has signed a contract with Merck to pre-order 500,000 courses of oral anti-coronavirus drug Molnupiravir (Molnupiravir).
After the drug is approved by the Ministry of Health, an additional 500,000 courses of drugs can be added.
The initial amount of oral drugs pre-ordered by Pfizer is 1 million courses.
Canadian Minister of Public Services and Procurement Filomena Tassi said that vaccination is still the best way to fight the new crown epidemic, but effective and easy-to-use treatments are essential to reduce the severity of the disease and help save lives.
At present, Canada has approved the use of four drugs or therapies for new coronary pneumonia, including Gilead’s Remdesivir (Remdesivir), Eli Lilly’s Bamlanivimab, Regeneron’s Casirivimab and Imdevimab combination, and GlaxoSmithKline’s Sotrovimab.
In addition, the National Immunization Advisory Committee of Canada issued its latest recommendations on the 3rd. It believes that the following populations can be vaccinated with the new crown vaccine booster (ie the third dose): people over 50 years of age, people living in long-term care institutions such as nursing homes, and aboriginal people Adults in the community, virus vector vaccine recipients, and front-line medical staff who have direct and close contact with patients, etc.
The committee also recommended that the interval between two doses of Pfizer vaccine for people aged 12-29 years should be increased to 8 weeks to reduce the risk of myocarditis.
The National Immunization Advisory Committee is a medical expert consulting organization that provides guidance on the use of various vaccines to the Canadian government.
(over)